Cullinan Therapeutics
CGEM
#6881
Rank
S$0.63 B
Marketcap
$10.86
Share price
-6.43%
Change (1 day)
-49.23%
Change (1 year)

Earnings for Cullinan Therapeutics (CGEM)

Earnings in 2024 (TTM): -S$0.25 Billion

According to Cullinan Therapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -S$0.26 Billion a decrease over its 2022 earnings that were of -S$0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cullinan Therapeutics from 2020 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$0.25 Billion-2.19%
2023 -S$0.26 Billion44.28%
2022 -S$0.18 Billion94.45%
2021 -S$90.57 Million12.63%
2020 -S$80.41 Million